Researcher
Patrik Verstreken
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurological and neuromuscular diseases
- See also: Patrik Verstreken (KU Leuven)
Affiliations
- Research Group Molecular Neurobiology (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Responsible
From1 Jan 2008 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Member
From1 Jan 2017 → Today - VIB-KU Leuven Center for Brain & Disease Research (Research Center)
Responsible
From1 Jan 2017 → Today - Verstreken Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Human Genetics (Department)
Member
From1 Apr 2009 → 31 Dec 2016
Projects
1 - 10 of 19
- A function for sleep-dependent tau dynamicsFrom1 Apr 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Keep your brain cool during a sleepless night (The Branco Weiss Fellowship for Marieke Hoekstra)From1 Nov 2023 → TodayFunding: Other international institutions, not mentioned elsewhere
- EMBO Postdoctoral fellowship voor Katrin LindaFrom1 Feb 2023 → TodayFunding: EMBL
- Synaptic resilience in Tau-induced neurodegenerationFrom1 Jan 2023 → TodayFunding: Other EU initiatives out of framework
- This grant is to support the work conducted by Patrik Verstreken on project Brain on a Chip Hands- On Training Workshops (VIB) to support hands-on "brain on a chip" trainings for researchers in the Neurodegeneration Challenge Network (NDCN)From1 Nov 2022 → TodayFunding: Other international institutions, not mentioned elsewhere
- EMBO Long-term fellowship for Nicolò CarranoFrom1 May 2022 → TodayFunding: EMBL
- VIB Grant for Verstreken Lab_Period:2022-01-01-2026-12-31From1 Jan 2022 → TodayFunding: FRI - Project driven research
- The Parkinson’s Interest Group (PIG) goes live!From1 Aug 2021 → 30 Apr 2022Funding: Other international institutions, not mentioned elsewhere
- Dissecting the link between astrocyte diversity and PD risk” to investigate how neurodegenerative diseases, including Parkinson’s disease, intersect with regional aspects of astrocyte identityFrom1 Jul 2021 → 31 Dec 2022Funding: Other international institutions, not mentioned elsewhere
- Understanding inherited and acquired genetic variation in Parkinson’s disease through single-cell multi-omics analyses: a unique data resourceFrom1 Mar 2021 → 29 Feb 2024Funding: Foreign foundations, funds with scientific view
Publications
1 - 10 of 44
- EndophilinA-dependent coupling between activity-induced calcium influx and synaptic autophagy is disrupted by a Parkinson-risk mutation.(2023)
Authors: Adekunle Bademosi, Marianna Decet, Nikolaos Louros, Ella Martin, Wim Versées, Frederic Rousseau, Joost Schymkowitz, Patrik Verstreken
Pages: 1402-1422.e13 - Neurodegeneration cell per cell.(2023)
Authors: Sriram Balusu, Roman Praschberger, Bart De Strooper, Patrik Verstreken
Pages: 767-786 - Neuronal identity defines a-synuclein and tau toxicity.(2023)
Authors: Roman Praschberger, Natalie Kaempf, Jasper Janssens, Eliana Nachman, Stein Aerts, Patrik Verstreken
Pages: 1-14 - Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1.(2023)
Authors: Julie Jacquemyn, Benjamin Pavie, Vinoy Vijayan, Ayse Kilic, Nikky Corthout, Patrik Verstreken
Pages: 19 - Tyrosyl-tRNA synthetase has a noncanonical function in actin bundling.(2023)
Authors: Laura Morant, Sven Bervoets, Akram Mokhtarzadeh Khanghahi, Patrik Verstreken, Albena Jordanova
Pages: 999 - Synaptic proteostasis in Parkinson's disease.(2022)
Authors: Eliana Nachman, Patrik Verstreken
Pages: 72-79 - A reference human induced pluripotent stem cell line for large-scale collaborative studies.(2022)
Authors: Carles Calatayud Aristoy, Patrik Verstreken, Laurin Heinrich
Pages: 1685-1702.e22 - The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects.(2022)
Authors: Patrik Verstreken
Pages: 4 - Nano-positioning and tubulin conformation contribute to axonal transport regulation of mitochondria along microtubules.(2022)
Authors: Marianna Decet, Patrik Verstreken
Pages: e2203499119 - Do we still need animals? Surveying the role of animal-free models in Alzheimer's and Parkinson's disease research.(2022)
Authors: Bart De Strooper, Patrik Verstreken
Pages: e110002
Patents
1 - 10 of 10
- OLIGONUCLEOTIDES FOR MODULATING SYNAPTOGYRIN-3 EXPRESSION (Inventor)
- TARGETING SYNAPTOGYRIN-3 IN TAUOPATHY TREATMENT (Inventor)
- TARGETING SYNAPTOGYRIN-3 IN TAUOPATHY TREATMENT (Inventor)
- TARGETING SYNAPTOGYRIN-3 IN TAUOPATHY TREATMENT (Inventor)
- TARGETING SYNAPTOGYRIN-3 IN TAUOPATHY TREATMENT (Inventor)
- Compounds for treatment of intractable epilepsy and DOORS syndrome (Inventor)
- Compounds for treatment of intractable epilepsy and DOORS syndrome (Inventor)
- TARGETING SYNAPTOGYRIN-3 IN TAUOPATHY TREATMENT (Inventor)
- Compounds for treatment of intractable epilepsy and DOORS syndrome (Inventor)
- Inhibition of Tau-mediated early synaptic dysfunction (Inventor)